Objective To study the role of uterine artery notch on color Doppler ultrasound and roll over test in prediction of PIH. Methods 100 women with high risk pregnancies were studied for presence or absence of uterine artery diastolic notch by Doppler ultrasound at 16-28 weeks. Same women were then subjected to roll over test at 28-32 weeks. Results The primary outcome was that uterine diastolic notching alone and combined together with roll over test shows a high specificity (98.53%) for predicting PIH than roll over test (76.47%) alone. PPV of uterine artery diastolic notching (83.33%) was higher than roll over test alone (54.29%) and both tests combined together (80%). Conclusion After analyzing all the results, it has been concluded that uterine artery Doppler notching is better predictor for PIH than roll over test or even combined Doppler ? Roll over test together.Keywords Uterine artery notching Á Color Doppler Á Roll over test Á Pregnancy induced hypertension
BACKGROUNDAtherosclerosis of coronary arteries may manifest as myocardial infarction and angina pectoris and that of central nervous system as non-haemorrhagic cerebrovascular accidents and transient ischaemic attacks.The objective of this study is to compare the efficacy of atorvastatin and rosuvastatin on various aspects of lipid profile, viz. serum total cholesterol, serum LDL-C, serum VLDL-C, serum HDL-C and serum triglycerides in Indian patients having dyslipidaemia in this part of country. MATERIALS AND METHODSThis was a randomised open study conducted on patients with abnormal lipid profile attending the OPD/ wards of Department of Medicine, Guru Nanak Dev Hospital, attached to Government Medical College, Amritsar in the year 2006. Based on our previous year OPD and indoor patients' records, the total number of patients with dyslipidaemia was 165. Thinking that 100 patients would be achievable within 1 year, so a total of 100 patients were included in the study and the patients were divided randomly by lottery method into two groups of 50 patients each, Group A was put on Atorvastatin 20 mg daily and Group B was put on Rosuvastatin 20 mg daily. Out of total 100 patients, 50 (50%) were males and 50 (50%) were females. In Group A and B, there were 25 (50%) males and 25 (50%) females each. Lipid profiles were recorded in every patient at 0, 6 weeks and then 12 weeks. RESULTSThis was a randomised open study conducted on patients with abnormal lipid profile attending the OPD/ wards of Department of Medicine, Guru Nanak Dev Hospital, attached to Government Medical College, Amritsar in the year 2006. Based on our previous year OPD and indoor patients' records, the total number of patients with dyslipidaemia was 165. Thinking that 100 patients would be achievable within 1 year so a total of 100 patients were included in the study and the patients were divided randomly by lottery method into two groups of 50 patients each; Group A was put on Atorvastatin 20 mg daily and Group B was put on Rosuvastatin 20 mg daily. Out of total 100 patients, 50 (50%) were males and 50 (50%) were females. In Group A and B, there were 25 (50%) males and 25 (50%) females each. Lipid profiles were recorded in every patient at 0, 6 weeks and then 12 weeks. CONCLUSIONRosuvastatin lowers total serum cholesterol, serum LDL-C, serum TG and raises serum HDL-C more significantly as compared to Atorvastatin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.